成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 369638-68-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 369638-68-6
Chemical Structure| 369638-68-6
Structure of 369638-68-6 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 369638-68-6 ]

Related Doc. of [ 369638-68-6 ]

Alternatived Products of [ 369638-68-6 ]
Product Citations

Product Details of [ 369638-68-6 ]

CAS No. :369638-68-6 MDL No. :MFCD09907674
Formula : C10H15N3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :FGAZCKUQQRDXOX-UHFFFAOYSA-N
M.W : 209.25 Pubchem ID :22046506
Synonyms :

Calculated chemistry of [ 369638-68-6 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.5
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 57.24
TPSA : 64.11 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.06
Log Po/w (XLOGP3) : 1.08
Log Po/w (WLOGP) : 1.94
Log Po/w (MLOGP) : 0.41
Log Po/w (SILICOS-IT) : 1.1
Consensus Log Po/w : 1.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.85
Solubility : 2.96 mg/ml ; 0.0141 mol/l
Class : Very soluble
Log S (Ali) : -2.02
Solubility : 2.01 mg/ml ; 0.00959 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.0
Solubility : 0.211 mg/ml ; 0.00101 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.63

Safety of [ 369638-68-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 369638-68-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 369638-68-6 ]

[ 369638-68-6 ] Synthesis Path-Downstream   1~16

  • 1
  • [ 5521-55-1 ]
  • [ 75-65-0 ]
  • [ 369638-68-6 ]
YieldReaction ConditionsOperation in experiment
72.7% With diphenyl phosphoryl azide; triethylamine; In toluene; for 8.0h;Reflux; 5-Methylpyrazin-2-carboxylic acid (13.81 g, 0.1 mol), tert-butanol (95 mL, 1 mol), triethylamine (27.9 mL, 0.2 mol) and diphenylphosphoryl azide (30.27 g, 0.11 mol) were mixed in 300 mL toluene, heated to reflux and reacted for 8 hours, and chromatographed on a silica gel column (petroleum ether - petroleum ether:ethyl acetate=20:1) to obtain a light yellow solid 15.2 g, at a yield of 72.7%.
70% With diphenyl phosphoryl azide; triethylamine; In toluene; for 6.0h;Reflux; A. tert-butyl 5-methylpyrazin-2-ylcarbamate; To a solution of 5-methylpyrazine-2-carboxylic acid (500 mg, 3.62 mmol) in toluene (12 mL) were added DPPA (0.85 mL, 3.98 mmol), TEA (1.01 mL, 7.24 mmol) and te/t-butanol (3.4 mL, 36.2 mmol). The reaction mixture was refluxed for 6 hours after which, it was partitioned between ethyl acetate and water. The organic layer was separated and the aqueous layer was extracted with ethyl acetate. The combined organic extracts were washed with brine, dried over MgSC^, celite filtered and concentrated under reduced pressure. The crude product was purified by flash chromatography using (10% Ethyl acetate/Hexane) as a solvent to afford title compound (530 mg, 70% yield).1H NMR (600 MHz, CDC13) delta 9.15 (s, 1H), 8.08 (s, 1H), 7.61 (s, 1H), 2.50 (s, 3H), 1.55 (s, 9H). MS m/z : 210 [M+l].
70% With diphenyl phosphoryl azide; triethylamine; In 1,4-dioxane; at 100℃; for 3.0h;Product distribution / selectivity; Step 1: To a solution of 2-methylpyrazine-5-carboxylic acid (10 g, 72.4 mmol) and TEA (20 mL, 108 mmol) in t-butanol (156 mL) and dioxanes (100 mL) was added diphenyl phosphorylazide (23.4 mL, 108 mmol) and the resulting solution was warmed at 100 C. for 3 hours and then cooled to room temperature overnight. The crude reaction mixture was concentrated in vacuo. Purification by chromatography (silica 0-15% ethyl acetate/hexanes) following trituration of impure fractions with ether afforded (5-methyl-pyrazin-2-yl)-carbamic acid tert-butyl ester (10.6 g, 70%): 1H NMR (300 MHz, CHLOROFORM-d) delta ppm 1.56 (s, 9H) 2.51 (s, 3H) 8.02 (br. s., 1H) 8.07-8.14 (m, 1H) 9.18 (d, J=1.13 Hz, 1H).
63% With diphenyl phosphoryl azide; N-ethyl-N,N-diisopropylamine; at 82℃;Inert atmosphere; To a flask fitted with overhead stirrer, condenser, thermometer and nitrogen line was added 5-methylpyrazine-2-carboxylic acid (1.0 eq), tert-butanol (3.5 vols) and di-isopropylethylamine (1.5 eq) under a nitrogen atmosphere. The mixture was heated to 82 C., then diphenylphosphorylazide (1.0 eq) was added over a time period of 5-14 hours, maintaining the temperature of the reaction mixture at approximately 82 C. The reaction mixture was stirred for at least 1.5 hours, and then cooled to approximately 60 C. A solution of 4% w/w sodium hydroxide (1.75 eq) was added over a period of 2 hours. The mixture was cooled to 15 C. over at least 5 hours then held at 15 C. for 3 hours. The batch was then filtered, and the solid slurry washed with water (2 vols). The batch was again slurry washed with water (2 vols). After drying at 55-60 C. overnight, the desired product was obtained as a solid (corrected yield 56-63%). 1H NMR delta (400 MHz CDCl3): 9.18 (s, 1H), 8.17 (bs, 1H), 8.11 (s, 1H), 2.51 (s, 3H), 1.56 (s, 9H)
With diphenyl phosphoryl azide; In 1,4-dioxane; for 12.0h;Reflux; Intermediate: te/t-butyl 5-methylpyrazin-2-ylcarbamate (29a) (29a)To a stirred solution of 5-methyl-2-carboxylic acid (138 g, 1.0 mol) in dioxane (1 L) was added te/t-BuOH (100 mL) and diphenylphosphoryazide (330 g) and the reaction mixture was heated at reflux for 12 hours. The reaction mixture was concentrated to dryness and the residue was purified by flash column chromatography (ethyl acetate/hexanes), then recrystalized from ether to provide te/t-butyl 5-methylpyrazin-2- ylcarbamate (29a).
With diphenyl phosphoryl azide; triethylamine; In 1,4-dioxane; at 100℃; for 3.0h; (1) 175 g of 5-methyl-2-pyrazinecarboxylic acid was suspended in 1 L of dioxane, then 1 L of t-butanol, 175 mL of triethylamine, and 287 mL of diphenyl azidophosphate were sequentially added to the suspension, and the reaction solution was heated to 100C. The obtained reaction solution was stirred at the same temperature for 3 hours and then cooled to room temperature, and the solvent was distilled off under reduced pressure. The residue was poured onto a saturated aqueous solution of sodium hydrogen carbonate, and the aqueous phase was extracted with ethyl acetate. The obtained extraction liquid was washed with a saturated aqueous solution of ammonium chloride and dried, and then the solvent was distilled off under reduced pressure. The obtained crude product was crystallized from acetonitrile, to obtain 158 g of the following Compound [1-1]. [Show Image] The spectral data of the compound represented by the above Formula [1-1] is presented below. 1H-NMR (CDCl3) delta: 9.15 (1H, s), 8.70 (1H, s), 7.41 (1H, brs), 2.51 (3H, s), 1.55 (9H, s). mass: 210 (M+1)+.
With diphenyl phosphoryl azide; triethylamine; In 1,4-dioxane; at 95℃; for 3.0h; Step 1. tert-butyl 5-methylpyrazin-2-ylcarbamate To solution 5-methylpyrazine-2-carboxylic acid (2.5 g, 18.1 mmol), tert-butanol (6.92 mL, 72.4 mmol), Et3N (3.78 mL, 27.1 mmol) in 1,4-dioxane (12.5 mL) at 95 C. was dropwise added diphenylphosphoryl azide (DPPA, 3.23 mL, 18.1 mmol), and the reaction was heated at 95 C. for 1.5 h, followed by a 2nd portion of DPPA (1 mL, 5.6 mmol) and heated for additional 1.5 h. The reaction mixture was cooled down, concentrated and the residue was diluted with EtOAc (50 mL), washed with water (30 mL), 3 M NaOH (30 mL), sat. NaHCO3 (30 mL) and brine (30 mL), dried over Na2SO4, and concentrated. The residue was purified by flashed chromatography on silica gel eluting with gradient EtOAc/CH2Cl2 (0-20%) to afford tert-butyl 5-methylpyrazin-2-ylcarbamate as white solid. LCMS (m/z): 210.1 (MH+), 0.69 min; 1H NMR (400 MHz, CDCl3) delta ppm 9.17 (s, 1H), 8.09 (s, 1H), 7.75 (br. s., 1H), 2.51 (s, 3H), 1.56 (s, 9H).

  • 2
  • [ 369638-68-6 ]
  • [ 369638-69-7 ]
YieldReaction ConditionsOperation in experiment
77% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile); In tetrachloromethane; at 100℃; for 4.0h;Product distribution / selectivity; Step 2: To a solution of <strong>[369638-68-6](5-methyl-pyrazin-2-yl)-carbamic acid tert-butyl ester</strong> (from above and from example 21, step 1, 12.9 g, 61.6 mmol) and AIBN (10.1 g, 61 mmol) in CCl4 (100 mL) was added NBS (11 g, 61.6 mmol) and the reaction mixture was stirred at 100 C. for 4 h. The reaction mixture was filtered, washed with CH2Cl2 and concentrated in vacuo. Purification by chromatography (silica, 4:5:1 CH2Cl2:hexanes:ethyl acetate) with repurification of mixed fractions by chromatography (silica, 4:5:1 CH2Cl2:hexanes:ethyl acetate) afforded a total of (5-bromomethyl-pyrazin-2-yl)-carbamic acid tert-butyl ester (13.6 g, 77%): 1H NMR (300 MHz, CHLOROFORM-d) delta ppm 1.57 (s, 9H) 4.55 (s, 2H) 8.15 (s, 1H) 8.34 (d, J=1.51 Hz, 1H) 9.28 (d, J=1.51 Hz, 1H).
75% With N-Bromosuccinimide;2,2'-azobis(isobutyronitrile); In tetrachloromethane; at 80℃; for 4.0h; B. tert-butyl 5-(bromomethyl)pyrazin-2-ylcarbamate; To a solution <strong>[369638-68-6]tert-butyl 5-methylpyrazin-2-ylcarbamate</strong> (500 mg, 2.39 mmol) in CC (8.0 niL) were added NBS(446 mg, 2.51 mmol) and AIBN (117 mg, 0.72 mmol). The reaction mixture was stirred for 4 hours at 80 C after which, it was partitioned between CH2CI2 and water. The organic layer was separated and the aqueous layer was extracted with CH2CI2. The combined organic extracts were washed with brine, dried over MgS04, celite filtered and concentrated under reduced pressure. The crude product was purified by flashchromatography using (10% Ethyl acetate/Hexane) as a solvent to afford title compound (520 mg, 75% yield). 1H NMR (600 MHz, CDC13) delta 9.29 (s, 1H), 8.95 (s, 1H), 8.37 (s, 1H), 4.38 (s, 2H), 1.57 (s, 9H). MS m/z : 288 [M+l].
With N-Bromosuccinimide; sodium hydrogencarbonate; In tetrachloromethane; at 80℃; for 12.0h; Intermediate: te/t-butyl 5-(bromomethyl)pyrazin-2-ylcarbamate (29b)BocHNgammaN.(29b)To a solution of te/t-butyl 5-methylpyrazin-2-ylcarbamate (29a) (100 g, 0.48 mol) inCCU (40 mL) was added NaHCO,? followed by AZ-bromosuccinimide (130 g, 0.57 mol). The resulting mixture was heated to reflux at 800C for 12 hours then cooled to room temperature. The reaction mixture was filtered through Cehte and the filtrate was concentrated in vacuo. The crude product was chromatographed (SiO?; 5 % EtOAc in CHCI3) to give tert-buty 5-{bromomethyi)pyrazm-2-y.carbamate (29b).
With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile); In tetrachloromethane; at 85℃; for 4.0h;Inert atmosphere; Step 2. tert-butyl 5-(bromomethyl)pyrazin-2-ylcarbamate:_A solution of <strong>[369638-68-6]tert-butyl 5-methylpyrazin-2-ylcarbamate</strong> (2.79 g, 13.33 mmol), NBS (2.61 g, 14.67 mmol) and AlBN (0.219 g, 1.33 mmol) in CCl4 (45 mL) was purged with Argon, then the solution was heated with 85 C. oil bath for 4 h. The reaction mixture was cooled to room temperature, concentrated and the residue was redissolved in EtOAc (?50 mL), washed with dilute aqueous NaOH twice (10 mL 1 N NaOH diluted in 20 mL H2O), brine (30 mL), dried (Na2SO4) and concentrated. The residue was further purified by flash chromatography on silica gel eluted with gradient EtOAc/CH2Cl2 (0-30%) and tert-butyl 5-(bromomethyl)pyrazin-2-ylcarbamate was obtained in off-white solid. LCMS (m/z): 288.1/290.1 (MH+), 0.82 min; 1H NMR (400 MHz, CDCl3) delta ppm 9.26 (s, 1H), 8.32 (d, J=1.2 Hz, 1H), 7.62 (br. s., 1H), 4.56 (s, 2H), 1.56 (s, 9H).

  • 3
  • [ 369638-68-6 ]
  • [ 874476-55-8 ]
  • 5
  • [ 369638-68-6 ]
  • [ 874476-57-0 ]
  • 6
  • [ 369638-68-6 ]
  • [ 874476-62-7 ]
  • 7
  • [ 369638-68-6 ]
  • [ 874476-59-2 ]
  • 8
  • [ 369638-68-6 ]
  • [ 874476-56-9 ]
  • 9
  • [ 369638-68-6 ]
  • [ 874476-63-8 ]
  • 10
  • [ 369638-68-6 ]
  • [ 874476-58-1 ]
  • 11
  • [ 369638-68-6 ]
  • [5-(2-cyclohexyloxy-6-methyl-pyrimidin-4-yl)-thiazol-2-yl]-[5-(4-methyl-piperazin-1-ylmethyl)-pyrazin-2-yl]-amine [ No CAS ]
  • 12
  • [ 369638-68-6 ]
  • [5-(<i>tert</i>-butyl-dimethyl-silanyloxymethyl)-pyrazin-2-yl]-[5-(6-methyl-2-methylsulfanyl-pyrimidin-4-yl)-3-(2-trimethylsilanyl-ethoxymethyl)-3<i>H</i>-thiazol-2-ylidene]-amine [ No CAS ]
  • 13
  • [ 369638-68-6 ]
  • {5-[5-(2-cyclohexyloxy-6-methyl-pyrimidin-4-yl)-3-(2-trimethylsilanyl-ethoxymethyl)-3<i>H</i>-thiazol-2-ylideneamino]-pyrazin-2-yl}-methanol [ No CAS ]
  • 14
  • [ 369638-68-6 ]
  • [5-(<i>tert</i>-butyl-dimethyl-silanyloxymethyl)-pyrazin-2-yl]-[5-(2-methanesulfonyl-6-methyl-pyrimidin-4-yl)-3-(2-trimethylsilanyl-ethoxymethyl)-3<i>H</i>-thiazol-2-ylidene]-amine [ No CAS ]
  • 15
  • [ 369638-68-6 ]
  • methanesulfonic acid 5-[5-(2-cyclohexyloxy-6-methyl-pyrimidin-4-yl)-3-(2-trimethylsilanyl-ethoxymethyl)-3<i>H</i>-thiazol-2-ylideneamino]-pyrazin-2-ylmethyl ester [ No CAS ]
  • 16
  • [ 369638-68-6 ]
  • [5-(<i>tert</i>-butyl-dimethyl-silanyloxymethyl)-pyrazin-2-yl]-[5-(2-cyclohexyloxy-6-methyl-pyrimidin-4-yl)-3-(2-trimethylsilanyl-ethoxymethyl)-3<i>H</i>-thiazol-2-ylidene]-amine [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 369638-68-6 ]

Amides

Chemical Structure| 920313-67-3

[ 920313-67-3 ]

tert-Butyl (5-aminopyrazin-2-yl)carbamate

Similarity: 0.81

Chemical Structure| 914349-79-4

[ 914349-79-4 ]

tert-Butyl (5-bromopyrazin-2-yl)carbamate

Similarity: 0.77

Chemical Structure| 1208542-95-3

[ 1208542-95-3 ]

tert-Butyl 4-(3-aminopyrazin-2-yl)piperazine-1-carboxylate

Similarity: 0.74

Chemical Structure| 220731-04-4

[ 220731-04-4 ]

tert-Butyl (5-aminopyridin-2-yl)carbamate

Similarity: 0.73

Chemical Structure| 1799412-29-5

[ 1799412-29-5 ]

tert-Butyl (3-acetylpyrazin-2-yl)carbamate

Similarity: 0.71

Amines

Chemical Structure| 920313-67-3

[ 920313-67-3 ]

tert-Butyl (5-aminopyrazin-2-yl)carbamate

Similarity: 0.81

Chemical Structure| 914349-79-4

[ 914349-79-4 ]

tert-Butyl (5-bromopyrazin-2-yl)carbamate

Similarity: 0.77

Chemical Structure| 1208542-95-3

[ 1208542-95-3 ]

tert-Butyl 4-(3-aminopyrazin-2-yl)piperazine-1-carboxylate

Similarity: 0.74

Chemical Structure| 220731-04-4

[ 220731-04-4 ]

tert-Butyl (5-aminopyridin-2-yl)carbamate

Similarity: 0.73

Chemical Structure| 1799412-29-5

[ 1799412-29-5 ]

tert-Butyl (3-acetylpyrazin-2-yl)carbamate

Similarity: 0.71

Related Parent Nucleus of
[ 369638-68-6 ]

Pyrazines

Chemical Structure| 920313-67-3

[ 920313-67-3 ]

tert-Butyl (5-aminopyrazin-2-yl)carbamate

Similarity: 0.81

Chemical Structure| 914349-79-4

[ 914349-79-4 ]

tert-Butyl (5-bromopyrazin-2-yl)carbamate

Similarity: 0.77

Chemical Structure| 1208542-95-3

[ 1208542-95-3 ]

tert-Butyl 4-(3-aminopyrazin-2-yl)piperazine-1-carboxylate

Similarity: 0.74

Chemical Structure| 1799412-29-5

[ 1799412-29-5 ]

tert-Butyl (3-acetylpyrazin-2-yl)carbamate

Similarity: 0.71

Chemical Structure| 86525-14-6

[ 86525-14-6 ]

1-(Pyrazin-2-yl)urea

Similarity: 0.52

; ;